SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann; Prerna Arora; Rüdiger Groß; Alina Seidel; Bojan F. Hörnich; Alexander S. Hahn; Nadine Krüger; Luise Graichen; Heike Hofmann-Winkler; Amy Kempf; Martin Sebastian Winkler; Sebastian Schulz; Hans‐Martin Jäck; Bernd Jahrsdörfer; Hubert Schrezenmeier; Martin Müller; Alexander Kleger; Jan Münch; Stefan Pöhlmann

doi:10.1016/j.cell.2021.03.036

Keywords

AntibodyVirologyBiologyViral entryNeutralizing antibodyPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirusRecombinant DNA2019-20 coronavirus outbreakImmunologyGeneViral replicationGeneticsMedicineDiseaseInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Yiska Weisblum , Fabian Schmidt , Fengwen Zhang +21 more

Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2. Moreover, passiv...

2020 eLife 1439 citations

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. García-Beltrán , Evan C. Lam , Kerri St. Denis +12 more

Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spi...

2021 Cell 1520 citations

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Thomas F. Rogers , Fangzhu Zhao , Deli Huang +31 more

Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neu...

2020 Science 1467 citations

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney , Tyler N. Starr , Pavlo Gilchuk +17 more

Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are being developed as therapeutics and are a major contributor to neutralizing antibody responses elicit...

2020 Cell Host & Microbe 1110 citations

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Xiaolong Tian , Cheng Li , Ailing Huang +8 more

The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 11,900 laboratory-confirmed human infections, including 259 deaths, posing a serious threat to human...

2020 Emerging Microbes & Infections 1257 citations

Publication Info

Year: 2021
Type: article
Volume: 184
Issue: 9
Pages: 2384-2393.e12
Citations: 1029
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1029

OpenAlex

Cite This

APA Style

                            
                                
                                    Markus Hoffmann, 
                                
                                    Prerna Arora, 
                                
                                    Rüdiger Groß
                                
                                et al.
                            
                            (2021). 
                            SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. 
                            Cell
                            , 184
                            (9)
                            , 2384-2393.e12.
                            https://doi.org/10.1016/j.cell.2021.03.036
                        

Identifiers

DOI: 10.1016/j.cell.2021.03.036